The elevated expression of GLUT1 and/or GLUT3 is associated with poor survival in many solid cancers, including gastric cancer [5], breast cancer [6], lung cancer [7], and glioblastoma [8]. This evidence concerns the gene SLC2A3 and glioblastoma.